Cytokeratin 8/18 Levels in Patients with Prostate Cancer and Benign Prostatic Hyperplasia

Publisher： Karger

E-ISSN： 1423-0399|60|3|152-155

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.60, Iss.3, 1998-06, pp. : 152-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Osteopontin Expression in Prostate Cancer and Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 62, Iss. 3, 1999-10 ,pp. : 155-158

Karger

Access to resources Recommend Favorite

Oxidative Stress in Benign Prostatic Hyperplasia and Prostate Cancer

By  

Urologia Internationalis, Vol. 85, Iss. 3, 2010-05 ,pp. : 328-333

Karger

Access to resources Recommend Favorite

Testosterone Levels in Benign Prostatic Hypertrophy and Prostate Cancer

By  

Urologia Internationalis, Vol. 80, Iss. 2, 2008-03 ,pp. : 134-140

Karger

Access to resources Recommend Favorite

Prostate-Specific Antigen Levels and Density in the Internal and External Glands of the Prostate in Benign Prostatic Hyperplasia Patients with Normal or Gray-Zone PSA Levels

By  

Urologia Internationalis, Vol. 71, Iss. 2, 2003-08 ,pp. : 154-159

Karger

Access to resources Recommend Favorite

Detection of Prostate Cancer and Changes in Prostate-Specific Antigen (PSA) Six Months after Surgery for Benign Prostatic Hyperplasia in Patients with Elevated PSA

By  

Urologia Internationalis, Vol. 71, Iss. 2, 2003-08 ,pp. : 150-153

Karger

Access to resources Recommend Favorite